Skip to main content

Featured

Re-positive COVID-19 case reported

(To watch the full press briefing with sign language interpretation, click here.)   The Centre for Health Protection today said it is investigating two additional imported COVID-19 cases and a preliminary positive local case which is likely to be a re-positive one.   The centre's Communicable Disease Branch Head Dr Chuang Shuk-kwan told a press briefing this afternoon that the preliminary positive local case involves a 43-year-old man who has not been vaccinated against the virus yet.   He worked at construction sites at 248 Queen's Road East and Shiu Kin Lane in Wan Chai, and last worked on August 3.   The patient has tested negative under the regular testing requirement since May. His deep throat saliva sample submitted via regular testing on August 2 preliminarily tested positive with a Ct value of 36 to 38, which indicates a low viral load.   After admission to hospital on August 3, the patient tested positive for COVID-19 antibodies.   Dr Chuang said: “There ma

EU vaccine exports monitored

The Government today said it is gravely concerned about the European Union's (EU) announcement of implementing an export control mechanism, and if necessary, banning the export of COVID-19 vaccines.   The EU's announcement stated that it will strive to ensure the new regulation does not affect the exports under advance purchase agreements already entered into between vaccine manufacturers and third parties.   The Government has proactively followed up with the vaccine manufacturers it has advance purchase agreements with to ensure that the vaccines procured can be supplied to Hong Kong as scheduled.   It has indicated to Fosun Pharma that it should reach out to the various relevant parties to ensure that the Fosun/BioNTech vaccine to be exported for supply to Hong Kong under the advance purchase agreement will not be affected.   The Government will closely monitor the development of the situation.   It will also continue to negotiate purchase agreements with vaccine manufacturers from around the world and the Mainland to obtain more supplies of vaccines which meet the criteria of safety, efficacy and quality, and strive for the early supply of the vaccines to Hong Kong.
http://dlvr.it/RrjBf6

Popular Posts